Gain Therapeutics, Inc. (GANX) stock
GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.18+0.24 (+25.51%)
Close on Nov 17, 2026Market cap $51.50MP/E –Yield –
Gain Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Gain Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$19.19M. For fiscal 2025 it was -$18.62M. The highest annual figure on record is -$3.47M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.62M | – |
| FY2024 | Dec 31, 2024 | -$20.27M | – |
| FY2023 | Dec 31, 2023 | -$22.17M | – |
| FY2022 | Dec 31, 2022 | -$17.71M | – |
| FY2021 | Dec 31, 2021 | -$13.81M | – |
| FY2020 | Dec 31, 2020 | -$3.47M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.44M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.35M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.16M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.36M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.38M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.86M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.71M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.21M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.54M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.73M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.28M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.51M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.46M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.61M | – |
| Q3 FY2020 | Sep 30, 2020 | -$816.71K | – |
| Q2 FY2020 | Jun 30, 2020 | -$530.19K | – |
| Q1 FY2020 | Mar 31, 2020 | -$510.16K | – |
See a number that looks wrong?